Mechanism of lncRNA and circRNA regulating the sensitivity of radiotherapy and chemotherapy in esophageal squamous cell carcinoma

doi:10.3760/cma.j.cn371439-20220104-00032

Abstract

Abstract:

Long non-coding RNA (lncRNA) and circular RNA (circRNA) are two important types of non-coding RNA that can regulate gene expression by directly interacting with DNA, RNA or protein. A large number of studies have shown that lncRNA and circRNA can not only predict the prognosis of patients with esophageal squamous cell carcinoma (ESCC) after radiotherapy and chemotherapy, but also affect the sensitivity of ESCC to radiotherapy and chemotherapy through competing endogenous RNA mechanisms, regulating PI3K/Akt/mTOR and Wnt/β-catenin signaling pathways, participating in DNA and protein modification, regulating the cell cycle and other pathways. In-depth research on the mechanism of lncRNA and circRNA regulating the sensitivity of ESCC to radiotherapy and chemotherapy will improve the effect of radiotherapy and chemotherapy in ESCC patients.

Key words: Esophageal neoplasms, Carcinoma,squamous cell, Radiotherapy, Chemotherapy, Long non-coding RNA, Circular RNA

Zhang Junpeng, Yu Yanyan, Li Baosheng. Mechanism of lncRNA and circRNA regulating the sensitivity of radiotherapy and chemotherapy in esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2022, 49(3): 185-189.

References 34

[1]	He Z, Ke Y. Precision screening for esophageal squamous cell carcinoma in China[J]. Chin J Cancer Res, 2020, 32(6):673-682. DOI: 10.21147/j.issn.1000-9604.2020.06.01. doi: 10.21147/j.issn.1000-9604.2020.06.01
[2]	中国医师协会放射肿瘤治疗医师分会; 中华医学会放射肿瘤治疗学分会; 中国抗癌协会肿瘤放射治疗专业委员会. 中国食管癌放射治疗指南(2020年版)[J]. 国际肿瘤学杂志, 2020, 47(11):641-655. DOI: 10.3760/cma.j.cn371439-20201015-00095. doi: 10.3760/cma.j.cn371439-20201015-00095
[3]	Ding M, Zhang E, He R, et al. Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy[J]. Cancer Sci, 2013, 104(11):1401-1410. DOI: 10.1111/cas.12252. doi: 10.1111/cas.12252
[4]	Yu J, Xu QG, Wang ZG, et al. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma[J]. J Hepatol, 2018, 68(6):1214-1227. DOI: 10.1016/j.jhep.2018.01.012. doi: 10.1016/j.jhep.2018.01.012
[5]	Ma J, Xiao Y, Tian B, et al. Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma[J]. J Cell Biochem, 2020, 121(2):1374-1387. DOI: 10.1002/jcb.29373. doi: 10.1002/jcb.29373
[6]	Tong YS, Zhou XL, Wang XW, et al. Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma[J]. J Transl Med, 2014, 12:233. DOI: 10.1186/s12967-014-0233-y. doi: 10.1186/s12967-014-0233-y
[7]	Zhou XL, Wang WW, Zhu WG, et al. High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy[J]. Mol Carcinog, 2016, 55(12):2095-2105. DOI: 10.1002/mc.22454. doi: 10.1002/mc.22454
[8]	Li ZY, Li HF, Zhang YY, et al. Value of long non-coding RNA Rpph1 in esophageal cancer and its effect on cancer cell sensitivity to radiotherapy[J]. World J Gastroenterol, 2020, 26(15):1775-1791. DOI: 10.3748/wjg.v26.i15.1775. doi: 10.3748/wjg.v26.i15.1775
[9]	Wang J, Chen Y, Wu R, et al. Circular RNA hsa_circ_0000554 promotes progression and elevates radioresistance through the miR-485-5p/fermitin family members 1 axis in esophageal cancer[J]. Anticancer Drugs, 2021, 32(4):405-416. DOI: 10.1097/CAD.000000-0000001007. doi: 10.1097/CAD.000000-0000001007
[10]	Qu F, Wang L, Wang C, et al. Circular RNA circ_0006168 enhances Taxol resistance in esophageal squamous cell carcinoma by regulating miR-194-5p/JMJD1C axis[J]. Cancer Cell Int, 2021, 21(1):273. DOI: 10.1186/s12935-021-01984-y. doi: 10.1186/s12935-021-01984-y
[11]	Lin J, Liu Z, Liao S, et al. Elevation of long non-coding RNA GAS5 and knockdown of microRNA-21 up-regulate RECK expression to enhance esophageal squamous cell carcinoma cell radio-sensitivity after radiotherapy[J]. Genomics, 2020, 112(3):2173-2185. DOI: 10.1016/j.ygeno.2019.12.013. doi: 10.1016/j.ygeno.2019.12.013
[12]	Liu J, Zhou R, Deng M, et al. Long non-coding RNA DIO3OS binds to microRNA-130b to restore radiosensitivity in esophageal squamous cell carcinoma by upregulating PAX9[J]. Cancer Gene Ther, 2021, In press. DOI: 10.1038/s41417-021-00344-2. doi: 10.1038/s41417-021-00344-2
[13]	Wang L, Wang X, Yan P, et al. LINC00261 suppresses cisplatin resistance of esophageal squamous cell carcinoma through miR-545-3p/MT1M axis[J]. Front Cell Dev Biol, 2021, 9:687788. DOI: 10.3389/fcell.2021.687788. doi: 10.3389/fcell.2021.687788
[14]	Chen X, Wang W, Li Y, et al. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling[J]. J Exp Clin Cancer Res, 2021, 40(1):341. DOI: 10.1186/s13046-021-02106-2. doi: 10.1186/s13046-021-02106-2
[15]	Liu G, Guo W, Chen G, et al. Lnc-MCEI mediated the chemosensitivity of esophageal squamous cell carcinoma via miR-6759-5p to competitively regulate IGF2[J]. Int J Biol Sci, 2020, 16(15):2938-2950. DOI: 10.7150/ijbs.47051. doi: 10.7150/ijbs.47051
[16]	Liu H, Zhang J, Luo X, et al. Overexpression of the long noncoding RNA FOXD2-AS1 promotes cisplatin resistance in esophageal squamous cell carcinoma through the miR-195/Akt/mTOR axis[J]. Oncol Res, 2020, 28(1):65-73. DOI: 10.3727/096504019-X15656904013079. doi: 10.3727/096504019-X15656904013079
[17]	Chen M, Liu P, Chen Y, et al. Long noncoding RNA FAM201A mediates the radiosensitivity of esophageal squamous cell cancer by regulating ATM and mTOR expression via miR-101[J]. Front Genet, 2018, 9:611. DOI: 10.3389/fgene.2018.00611. doi: 10.3389/fgene.2018.00611
[18]	Wang M, Wang L, He X, et al. lncRNA CCAT2 promotes radiotherapy resistance for human esophageal carcinoma cells via the miR-145/p70S6K1 and p53 pathway[J]. Int J Oncol, 2020, 56(1):327-336. DOI: 10.3892/ijo.2019.4929. doi: 10.3892/ijo.2019.4929
[19]	Wang P, Yang Z, Ye T, et al. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET[J]. J Exp Clin Cancer Res, 2020, 39(1):7. DOI: 10.1186/s13046-019-1519-y. doi: 10.1186/s13046-019-1519-y
[20]	He Y, Mingyan E, Wang C, et al. CircVRK1 regulates tumor progression and radioresistance in esophageal squamous cell carcinoma by regulating miR-624-3p/PTEN/PI3K/AKT signaling pathway[J]. Int J Biol Macromol, 2019, 125:116-123. DOI: 10.1016/j.ijbiomac.2018.11.273. doi: 10.1016/j.ijbiomac.2018.11.273
[21]	Zhang S, Jiang H, Xu Z, et al. The resistance of esophageal cancer cells to paclitaxel can be reduced by the knockdown of long nonco-ding RNA DDX11-AS1 through TAF1/TOP2A inhibition[J]. Am J Cancer Res, 2019, 9(10):2233-2248.
[22]	Zou FW, Yang SZ, Li WY, et al. CircRNA_001275 upregulates Wnt7a expression by competitively sponging miR-370-3p to promote cisplatin resistance in esophageal cancer[J]. Int J Oncol, 2020, 57(1):151-160. DOI: 10.3892/ijo.2020.5050. doi: 10.3892/ijo.2020.5050
[23]	Liu J, Xue N, Guo Y, et al. CircRNA_100367 regulated the radiation sensitivity of esophageal squamous cell carcinomas through miR-217/Wnt3 pathway[J]. Aging (Albany NY), 2019, 11(24):12412-12427. DOI: 10.18632/aging.102580. doi: 10.18632/aging.102580
[24]	Li N, Zhao Z, Miao F, et al. Silencing of long non-coding RNA LINC01270 inhibits esophageal cancer progression and enhances chemosensitivity to 5-fluorouracil by mediating GSTP1methylation[J]. Cancer Gene Ther, 2021, 28(5):471-485. DOI: 10.1038/s41417-020-00232-1. doi: 10.1038/s41417-020-00232-1
[25]	Chen JL, Lin ZX, Qin YS, et al. Overexpression of long noncoding RNA LINC01419 in esophageal squamous cell carcinoma and its relation to the sensitivity to 5-fluorouracil by mediating GSTP1 methy-lation[J]. Ther Adv Med Oncol, 2019, 11:1758835919838958. DOI: 10.1177/1758835919838958. doi: 10.1177/1758835919838958
[26]	Zhang S, Zheng F, Zhang L, et al. LncRNA HOTAIR-mediated MTHFR methylation inhibits 5-fluorouracil sensitivity in esophageal cancer cells[J]. J Exp Clin Cancer Res, 2020, 39(1):131. DOI: 10.1186/s13046-020-01610-1. doi: 10.1186/s13046-020-01610-1
[27]	Lin K, Jiang H, Zhuang SS, et al. Long noncoding RNA LINC00261 induces chemosensitization to 5-fluorouracil by mediating methylation-dependent repression of DPYD in human esophageal cancer[J]. FASEB J, 2019, 33(2):1972-1988. DOI: 10.1096/fj.201800759R. doi: 10.1096/fj.201800759R
[28]	Zhang S, Liao W, Wu Q, et al. LINC00152 upregulates ZEB1 expression and enhances epithelial-mesenchymal transition and oxaliplatin resistance in esophageal cancer by interacting with EZH2[J]. Cancer Cell Int, 2020, 20(1):569. DOI: 10.1186/s12935-020-01620-1. doi: 10.1186/s12935-020-01620-1
[29]	Liu Z, Gu S, Wu K, et al. CircRNA-DOPEY2 enhances the chemosensitivity of esophageal cancer cells by inhibiting CPEB4-mediated Mcl-1 translation[J]. J Exp Clin Cancer Res, 2021, 40(1):361. DOI: 10.1186/s13046-021-02149-5. doi: 10.1186/s13046-021-02149-5
[30]	Liu Z, Lu X, Wen L, et al. Hsa_circ_0014879 regulates the radiosensitivity of esophageal squamous cell carcinoma through miR-519-3p/CDC25A axis[J]. Anticancer Drugs, 2022, 33(1):e349-e361. DOI: 10.1097/CAD.0000000000001213. doi: 10.1097/CAD.0000000000001213
[31]	Liu WH, Qiao HY, Xu J, et al. LINC00473 contributes to the radioresistance of esophageal squamous cell carcinoma by regulating microRNA-497-5p and cell division cycle 25A[J]. Int J Mol Med, 2020, 46(2):571-582. DOI: 10.3892/ijmm.2020.4616. doi: 10.3892/ijmm.2020.4616
[32]	Li YJ, Lei YH, Yao N, et al. Autophagy and multidrug resistance in cancer[J]. Chin J Cancer, 2017, 36(1):52. DOI: 10.1186/s40880-017-0219-2. doi: 10.1186/s40880-017-0219-2
[33]	Zhu ZJ, Pang Y, Jin G, et al. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis[J]. Aging (Albany NY), 2021, 13(13):17155-17176. DOI: 10.18632/aging.203062. doi: 10.18632/aging.203062
[34]	Tong Y, Yang L, Yu C, et al. Tumor-secreted exosomal lncRNA POU3F3 promotes cisplatin resistance in ESCC by inducing fibroblast differentiation into CAFs[J]. Mol Ther Oncolytics, 2020, 18:1-13. DOI: 10.1016/j.omto.2020.05.014. doi: 10.1016/j.omto.2020.05.014